Deep Learning in Drug Discovery market Professional Survey Report by 2035

The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost.

This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning technology / solutions within the healthcare industry. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.

 

The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:

  • Therapeutic Area
  • Oncological Disorders
  • Infectious Diseases
  • Neurological Disorders
  • Immunological Disorders
  • Endocrine Disorders
  • Cardiovascular Disorders
  • Respiratory Disorders
  • Ophthalmic Disorders
  • Musculoskeletal Disorders
  • Inflammatory Disorders
  • Other Disorders

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World 

 

The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:

  • Aegicare
  • Aiforia Technologies
  • Ardigen
  • Berg
  • Google
  • Huawei
  • Merative
  • Nference
  • NVIDIA
  • Owkin
  • Phenomic AI
  • Pixel AI

 

Table of Contents

 

  1. PREFACE

 

  1. EXECUTIVE SUMMARY

 

  1. INTRODUCTION

 

  1. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY

 

  1. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS

 

  1. COMPANY PROFILES

 

  1. PORTER’S FIVE FORCES ANALYSIS

 

  1. CLINICAL TRIAL ANALYSIS

 

  1. FUNDING AND INVESTMENT ANALYSIS

 

  1. START-UP HEALTH INDEXING

 

  1. COMPANY VALUATION ANALYSIS

 

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY

 

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS

 

  1. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS

 

  1. CONCLUDING REMARKS

 

  1. INTERVIEW TRANSCRIPTS

 

  1. APPENDIX 1: TABULATED DATA

 

  1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html

 

Learn from experts:  do you know about these emerging industry trends?

Key Trends in Non-Viral Transfection Market

Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

 

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com


Michaeljohnson

12 Blog posts

Comments